WST09 (TOOKAD) mediated photodynamic therapy as an alternative modality in treatment of prostate cancer

Proceedings of SPIE - The International Society for Optical Engineering

Volumn 4612, Issue 1, 2002, Pages 29-39

  Chen, Qun ^a   Huang, Zheng ^a   Luck, David ^a   Beckers, Jill ^a   Brun, Pierre Herve ^c   Wilson, Brian C ^d   Scherz, Avigdor ^b   Salomon, Yoram ^b   Hetzel, Fred W ^a  

^a Highlands Presbyterian St Luke's Podiatric Medicine and Surgery Residency Program   (United States)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c Preclinical and Pharmacokinetics Department   (France)

^d PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Optical dosimetry; Photodynamic therapy; Prostate cancer; Tissue response; WST09(TOOKAD)

Indexed keywords

DOSIMETRY; LASER TISSUE INTERACTION; PATHOLOGY; PHOTOSENSITIZERS; SEMICONDUCTOR LASERS; TUMORS;

OPTICAL DOSIMETRY;

PHOTODYNAMIC THERAPY;

EID: 0036401530     PISSN: 0277786X     EISSN: None     Source Type: Journal    
DOI: 10.1117/12.469351     Document Type: Article

References (28)

1. Boring C.C., Squires T.X., Tong T., et al. Cancer Statistics 1994. CA J. Clin.44:7, 1994.
2. Paulson D.F. Randomized series of treatment with surgery versus radiation for prostate adenocarcinoma In: Wittes, R.I. ed. Consensus Development Conference on the Management of Clinically Localized Prostate Cancer. NCI Monographs. No. 7. Washington DC, Government Printing Office, 1988:117-22 (NIH publication No. 88-3005).
3. Catalona W.J. Management of cancer of The Prostate. NEJM 331:996, 1994.
4. Lepor H. and Walsh P.C. Long-term results of radical prostatectomy in clinically localized prostate cancer: experience at the John Hopkins Hospital. In: Wittes R.I. ed. Cancerous Development Conference on the Management of Clinically Localized Prostate Cancer. NCI Monographs. No. 7, Washington DC, Government Printing Office 1988:117-22 (NIH publication No. 88-3005).
5. Stamey T.A. Irradiation as primary treatment for prostate cancer. AUA Today 6:14, 1993.
6. Henderson B.W. and Dougherty T.J. How photodynamic therapy works? Photochem. Photobiol.: 55-145-157, 1992.
7. Chen Q. and Hetzel F.W. Laser dosimetry Studies in the Prostate. J. Clin Laser Med Surg. 16, 9-12, 1998.
8. Lee L.K., Whitehurst C., Pantelides M.L. and Moore J.V. In situ comparison of 665 and 632 nm wavelength light penetration in the human prostate gland. Photochem. Photobiol., 62:882-886, 1995.
9. Scherz A., Salomon Y. Scheer H. and Brandis, A., (1999) International PCT Patent Application No. PCT/IL99/00673, "Palladium-substituted bacteriochlorophyll derivatives and use thereof".
10. Brandis, A., Mazor, O., Gross, S., Koudinova, N., Hammi, R., Kälin-Kammhuber, N., Rosenbach-Belkin, V., Greenwald, M., Bondon, A, Simonneaux, G., Scheer, H., Salomon, Y. and Scherz A. (2001). Palladium-Bacteriochlorophyll derivatives: Synthesis and Phototoxicity (submitted).
11. Zilberstein, J., Schreiber, S., Bloemers, M.C.W.M., Bendel, P., Neeman, M., Schechtman, E., Kohen, F., Scherz, A., Salomon Y. (2001) Anti vascular treatment of solid melanoma tumors with bacteriochlorophyll-serine-based photodynamic therapy, Photochem. Photobiol. 73 257-263.
12. Chen Q., Wilson B.C., Shetty S.D., Patterson M.S., Cerny J.C., Hetzel F.W.: Changes in In Vivo Optical Properties and Light Distributions in Normal Canine Prostate During Photodynamic Therapy. Radiat. Res. 147,86-91 1997.
13. Wagnieres G., Hadjur C., Grosjean P., Braichotte D., Savary J.F., Monnier P., van den Bergh H. Clinical evaluation of the cutaneous phototoxicity of 5,10,15,20-tetra(m-hydroxyphenyl)chlorin. Photochem Photobiol (1998 Sep) 68(3):382-7.
14. van Geel I.P., Oppelaar H., Oussoren Y.G., van der Valk M.A., Stewart F.A.: Photosensitizing efficacy of MTHPC-PDT compared to photofrin-PDT in the RIF1 mouse tumour and normal skin. Int J Cancer (1995 Jan 27) 60(3):388-94.
15. Chen J.Y., Mak N.K., Wen J.M., Leung W.N., Chen S.C., Fung M.C., Cheung N.H. A comparison of the photodynamic effects of temoporfin (mTHPC) and MC540 on leukemia cells: efficacy and apoptosis. Photochem Photobiol., 68(4):545-54, 1998.
16. Regula J., Ravi B., Bedwell J., MacRobert A.J., Bown S.G.: Photodynamic therapy using 5-aminolaevulinic acid for experimental pancreatic cancer-prolonged animal survival. Br J Cancer 70:248-254, 1994.
17. Bedwell J., MacRobert A.J., Phillips D., Bown S.G.: Fluorescence distribution and photodynamic effect of ALA-induced PpIX in the DMH rat colonic tumor model. Br J Cancer 65:818-824, 1992.
18. Barr H., Krasner N., Boulos P.B., Chatlani P., Bown S.G.: Photodynamic therapy for colorectal cancer: a quantitative pilot study. Br. J Surg. 77:93-96, 1990.
19. Koudinova, N., Pinthus, J.H., Brandis, A., Mazor, O., Brenner, O., Bendel, P., Ramon J., Eshhar, Z., Scherz, A. Salomon. Y. (2001) Curative And Palliative Effects Of A Novel Photodynamic Agent (Pd Bacteriopheophorbide) On Prostate Cancer: In Vivo Studies Using Human Prostate Cancer Xenografts 8th Annual Scientific Retreat CapCURE Annual Retreat, Lake Tahoe Nevada, Sept. 2001 (www.capcure.org).
20. Koudinova, N., Pinthus, J.H., Brandis, A., Brenner, O., Bendel, P., Ramon J., Eshhar, Z., Scherz, A. Salomon, Y. (2001) TOOKAD Based Photodynamic Therapy: Successful In Vivo Treatment Of Human Prostatic Small Cell Carcinoma Xenografts (submitted).
21. Selman S.H., Keck R.W., Hampton J.A. Transperineal photodynamic ablation of the canine prostate. J. Urol. 156(1):258-60, 1996.
22. Selman S.H., Keck R.W. The effect of transurethral light on the canine prostate after sensitization with the photosensitizer tin (II) etiopurpurin dichloride: a pilot study. J. Urol. 152(6 Pt 1):2129-32, 1994.
23. Lee L.K., Whitehurst C., Chen Q., Pantelides M.L., Hetzel F.W., Moore J.V.: Interstitial Photodynamic Therapy in the Canine Prostate. Br. J. Urol. 80,898-902, 1997.
24. McPhee M.S., Thorndyke C.W., Thomas G., Tulip J., Chapman D., Lakey W.H. Interstitial applications of laser irradiation in hematoporphyrin derivative-photosensitized Dunning R3327 prostate cancers. Lasers Surg. Med. 4(1):93-8, 1984.
25. Momma T., Hamblin M.R., Wu H.C., Hasan T. Photodynamic therapy of orthotopic prostate cancer with benzoporphyrin derivative: local control and distant metastasis. Cancer Res. 58,5425-5431, 1988.
26. Chang, S., Buonaccorsi, G.A., MacRobert, A.J., and Bown, S.G., (1997). Interstitial Photodynamic Therapy in the Canine Prostate With Disulfonated Aluminum Phthalocyanine and 5-Aminolevulinic Acid-induced Protoporphyrin IX. The Prostate, Vol. 32, pp. 89-98.
27. Chang, S., Buonaccorsi, G., MacRobert, A., Bown, S.G., (1996). Interstitial and Transurethral Photodynamic Therapy of the Canine Prostate Using Meso-Tetra-(m-Hydroxyphenyl) Chlorin. Int. J. Cancer, Vol. 67, pp. 555-562.
28. Hsi, R.A., Kapatkin, A., Strandberg, J., Zhu, T., Vulcan, T., Solonenko, M., Rodriguez, C., Chang, J., Saunders, M., Mason, N., and Hahn, S., (2001). Photodynamic Therapy in the Canine Prostate Using Motexafin Lutetium. Clinical Cancer Research, Vol. 7, pp. 651-660.